Matinas BioPharma Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/4/2026

1. KRG
2. ALAR
3. SPY
4. PBA
5. CCH:LN
6. META
7. CCHGY
8. PRY:IM
9. PRYMY
10. SKA-B

Go back to Matinas BioPharma Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights

Matinas BioPharma (MTNB) Reports In-Line Q4 EPS

March 8, 2022 6:33 AM EST

Matinas BioPharma (NYSE: MTNB) reported Q4 EPS of ($0.03), in-line with the analyst estimate of ($0.03).

For earnings history and earnings-related data on Matinas BioPharma (MTNB) click here.

... More